av/surgalign--big.svg

COM:SURGALIGN

Xtant Medical

  • Stock

Last Close

0.18

17/09 20:00

Market Cap

1.68M

Beta: -

Volume Today

8.72M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
91.32M
-
109.80M
20.23%
116.07M
5.71%
119.21M
2.70%
115.83M
2.83%
109.70M
5.30%
66.02M
39.81%
23.71M
64.09%
24.52M
3.44%
21.96M
10.46%
average payables
17.59M
-
25.03M
42.31%
23.64M
5.56%
23.28M
1.53%
22.18M
4.71%
22.28M
0.44%
18.27M
17.99%
11.83M
35.27%
11.81M
0.14%
8.95M
24.19%
average receivables
26.72M
-
35.29M
32.07%
43.04M
21.95%
44.37M
3.08%
43.81M
1.24%
49.21M
12.31%
39.14M
20.46%
26.55M
32.16%
23.15M
12.81%
17.63M
23.84%
book value per share
2.99
-
2.96
0.97%
3.15
6.41%
2.83
10.04%
3.04
7.53%
2.89
5.07%
14.78
411.34%
9.75
34.07%
2.02
79.32%
-3.92
294.72%
capex per share
-0.28
-
-0.29
1.57%
-0.32
10.10%
-0.31
2.63%
-0.24
20.82%
-0.23
4.94%
-7.03
2,929.15%
-5.66
19.46%
-3.44
39.16%
-1.11
67.86%
capex to depreciation
-1.31
-
-1.06
18.81%
-1.10
4.17%
-1.09
1.50%
-1.02
5.83%
-1.01
1.21%
-0.72
28.35%
-2.13
194.34%
-5.68
166.11%
-3.32
41.44%
capex to operating cash flow
3.58
-
-2.37
166.18%
-2.03
14.33%
-1.17
42.21%
-5.93
406.47%
-0.88
85.19%
1.74
297.80%
0.16
90.82%
0.27
70.40%
0.14
48.75%
capex to revenue
-0.08
-
-0.06
22.83%
-0.06
4.08%
-0.07
1.83%
-0.05
20.80%
-0.05
0.70%
-0.14
166.71%
-0.14
1.41%
-0.16
12.70%
-0.09
43.08%
cash per share
0.33
-
0.28
16.83%
0.22
20.89%
0.24
8.61%
0.37
57.69%
0.17
54.03%
2.40
1,291.38%
17.73
639.11%
12.55
29.20%
2.49
80.19%
days of inventory on hand
328.62
-
321.01
2.32%
326.78
1.80%
311.04
4.82%
298.11
4.16%
278.73
6.50%
273.65
1.82%
189.47
30.76%
321.22
69.54%
155.05
51.73%
days payables outstanding
71.94
-
75.92
5.54%
56.30
25.84%
67.83
20.47%
48.61
28.33%
68.23
40.36%
113.99
67.05%
111.30
2.35%
125.09
12.38%
67.46
46.07%
days sales outstanding
58.54
-
53.93
7.87%
61.08
13.26%
55.50
9.15%
60.24
8.55%
67.93
12.77%
80.82
18.98%
97.20
20.26%
77.42
20.34%
71.49
7.66%
debt to assets
0.18
-
0.18
0.28%
0.21
13.85%
0.23
8.36%
0.13
40.84%
0.14
1.41%
0.00
97.93%
0.01
88.72%
0.08
1,422.11%
0.15
79.95%
debt to equity
0.40
-
0.41
2.65%
0.44
6.18%
0.51
15.09%
0.26
49.54%
0.27
4.80%
0.03
89.53%
0.03
3.88%
1.21
4,406.21%
-0.40
132.69%
dividend yield
0.00
-
earnings yield
-0.00
-
0.00
110.22%
0.00
613.62%
-0.00
216.66%
0.00
133.69%
-0.00
120.75%
-1.29
729,972.41%
-1.19
7.92%
-1.40
17.42%
-4.19
199.12%
enterprise value
6.02B
-
8.91B
47.90%
6.93B
22.25%
5.75B
17.04%
7.37B
28.14%
7.09B
3.75%
187.57M
97.35%
119.63M
36.22%
46.52M
61.11%
6.94M
85.08%
enterprise value over ebitda
-372.37
-
425.53
214.27%
168.05
60.51%
8.15K
4,751.18%
170.76
97.91%
602.86
253.04%
1.44
99.76%
-1.66
215.75%
2.49
249.75%
-0.10
104.08%
ev to operating cash flow
-1.35K
-
1.29K
195.55%
770.18
40.42%
375.09
51.30%
3.00K
699.81%
422.62
85.91%
-19.84
104.69%
-1.36
93.15%
-0.90
33.90%
-0.13
85.17%
ev to sales
30.43
-
33.91
11.42%
24.54
27.61%
21.06
14.18%
26.35
25.07%
25.24
4.19%
1.60
93.67%
1.18
26.40%
0.51
56.28%
0.08
83.53%
free cash flow per share
-0.36
-
-0.17
54.17%
-0.16
3.38%
-0.05
71.86%
-0.20
349.53%
0.03
115.80%
-11.07
34,625.27%
-41.16
271.75%
-16.12
60.84%
-9.06
43.81%
free cash flow yield
-0.00
-
-0.00
68.80%
-0.00
26.55%
-0.00
65.63%
-0.00
256.34%
0.00
117.51%
-0.13
46,721.71%
-0.63
365.11%
-0.75
19.71%
-4.55
506.82%
graham net net
-1.89
-
-1.92
1.53%
-1.60
16.38%
-1.69
5.30%
-0.86
49.15%
-1.16
35.15%
-116.56
9,949.44%
-9.21
92.10%
-9.00
2.24%
-8.97
0.36%
graham number
4.61
-
1.78
61.45%
4.28
140.78%
3.97
7.31%
2.68
32.40%
1.13
57.84%
188.10
16,526.89%
131.03
30.34%
36.93
71.81%
27.12
26.56%
income quality
0.25
-
2.56
922.73%
0.60
76.41%
-1.06
276.44%
0.39
136.78%
-13.42
3,528.32%
0.04
100.33%
2.61
5,732.66%
0.41
84.30%
0.95
133.17%
intangibles to total assets
0.24
-
0.23
6.08%
0.21
5.49%
0.21
0.71%
0.20
6.51%
0.24
19.04%
0.03
87.23%
0
100%
0
0
interest coverage
-52.87
-
4.15
107.84%
16.50
298.17%
-9.47
157.41%
9.06
195.62%
-0.90
109.96%
8.58
1,050.51%
-2.54K
29,650.95%
0.16
100.01%
-69.81
43,950.03%
interest debt per share
1.21
-
1.25
2.82%
1.41
12.90%
1.46
3.64%
0.83
43.15%
0.82
1.64%
5.79
609.36%
0.27
95.26%
27.34
9,856.18%
1.71
93.75%
inventory turnover
1.11
-
1.14
2.37%
1.12
1.77%
1.17
5.06%
1.22
4.34%
1.31
6.95%
1.33
1.86%
1.93
44.43%
1.14
41.02%
2.35
107.18%
invested capital
0.40
-
0.41
2.65%
0.44
6.18%
0.51
15.09%
0.26
49.54%
0.27
4.80%
0.03
89.53%
0.03
3.88%
1.21
4,406.21%
-0.40
132.69%
market cap
5.97B
-
8.85B
48.14%
6.86B
22.48%
5.68B
17.25%
7.34B
29.29%
7.05B
3.95%
192.21M
97.27%
162.94M
15.23%
87.83M
46.10%
13.04M
85.15%
net current asset value
-15.14M
-
-12.80M
15.44%
-8.00M
37.56%
-22.82M
185.45%
21.50M
194.23%
-2M
109.30%
-114.13M
5,606.55%
5.65M
104.95%
-9.89M
275.11%
-39.26M
296.97%
net debt to ebitda
-3.11
-
2.87
192.40%
1.63
43.44%
98.58
5,963.62%
0.56
99.44%
3.24
483.55%
-0.04
101.10%
0.60
1,793.74%
-2.21
467.25%
0.09
104.04%
net income per share
-0.32
-
0.05
115.01%
0.26
444.82%
-0.25
195.50%
0.11
142.50%
-0.02
118.73%
-106.39
540,548.20%
-78.30
26.40%
-30.08
61.59%
-8.33
72.30%
operating cash flow per share
-0.08
-
0.12
253.48%
0.16
28.51%
0.26
68.50%
0.04
84.37%
0.26
541.98%
-4.04
1,631.38%
-35.50
777.81%
-12.67
64.30%
-7.95
37.28%
payables turnover
5.07
-
4.81
5.25%
6.48
34.84%
5.38
16.99%
7.51
39.53%
5.35
28.76%
3.20
40.14%
3.28
2.41%
2.92
11.02%
5.41
85.43%
receivables turnover
6.24
-
6.77
8.54%
5.98
11.71%
6.58
10.07%
6.06
7.88%
5.37
11.32%
4.52
15.95%
3.76
16.85%
4.71
25.54%
5.11
8.30%
research and ddevelopement to revenue
0.08
-
0.06
23.21%
0.05
9.72%
0.06
10.49%
0.05
18.87%
0.05
7.24%
0.14
179.45%
0.12
18.11%
0.15
30.70%
0.19
25.08%
return on tangible assets
-0.06
-
0.01
114.52%
0.05
440.36%
-0.05
200.15%
0.02
145.54%
-0.00
120.04%
-0.74
16,287.47%
-1.58
112.49%
-0.99
37.27%
-0.78
21.70%
revenue per share
3.52
-
4.63
31.63%
4.90
5.78%
4.69
4.38%
4.68
0.03%
4.42
5.61%
50.22
1,035.75%
41.03
18.30%
22.15
46.02%
12.51
43.53%
roe
-0.11
-
0.02
115.15%
0.08
411.98%
-0.09
206.16%
0.03
139.53%
-0.01
119.73%
-7.20
105,632.23%
-8.03
11.63%
-14.92
85.71%
2.12
114.22%
roic
-0.07
-
0.01
119.84%
0.06
298.93%
-0.05
187.91%
0.03
159.12%
-0.00
107.82%
3.03
125,840.57%
-3.03
200.14%
0.88
129.12%
4.45
404.03%
sales general and administrative to revenue
0.02
-
1.16
-
1.17
1.13%
shareholders equity per share
2.99
-
2.96
0.97%
3.15
6.41%
2.83
10.04%
3.04
7.53%
2.89
5.07%
14.78
411.34%
9.75
34.07%
2.02
79.32%
-3.92
294.72%
stock based compensation to revenue
0.01
-
0.01
2.89%
0.01
21.76%
0.01
45.76%
0.02
81.07%
0.02
29.08%
0.04
120.13%
0.06
72.51%
0.06
10.24%
0.06
1.85%
tangible asset value
79.38M
-
82.69M
4.17%
100.26M
21.25%
86.03M
14.18%
112.42M
30.67%
97.47M
13.30%
24.07M
75.30%
24.17M
0.41%
8.24M
65.92%
-25.73M
412.36%
tangible book value per share
1.41
-
1.46
3.29%
1.74
19.41%
1.48
15.11%
1.88
27.50%
1.53
18.54%
10.29
570.91%
9.75
5.33%
2.02
79.32%
-3.92
294.72%
working capital
134.30M
-
133.51M
0.59%
131.78M
1.29%
121.33M
7.93%
132.68M
9.35%
119.66M
9.81%
-44.57M
137.25%
57.36M
228.68%
51.63M
9.99%
35.56M
31.12%

All numbers in (except ratios and percentages)